Skip to main content
Table of Contents
Print

Are There Risks in Combining Cannabis with Supplements in ME/CFS? 

Author: Dr. Clarissa Morton, PharmD

As more patients turn to integrated therapies, the question of the risks of cannabis and supplements in ME/CFS is becoming increasingly relevant. Many people with ME/CFS already rely on nutritional supplements to manage symptoms, and introducing cannabis adds a layer of complexity worth understanding. 

The Importance of Knowing What You’re Combining 

The body processes cannabinoids and supplements through shared pathways, primarily in the liver. That means combining both without medical guidance can lead to unexpected results. Exploring the risks of cannabis and supplements in ME/CFS is about ensuring that support doesn’t turn into strain, especially for those already dealing with fragile systems. 

This concern has led to growing awareness around potential cannabis and supplement interactions in ME/CFS, particularly when high-dose supplements or specific herbal remedies are involved. 

What Patients Should Consider When Combining Cannabis and Supplements 

Taking both supplements and cannabis may be safe in many cases, but there are still factors worth considering. 

Liver Load and Metabolism 

Both cannabis and certain supplements (like St John’s Wort or high-dose antioxidants) are metabolised in the liver. This overlap may increase the risk of cannabis and supplement side effects in ME/CFS, such as fatigue or digestive upset. 

Blood Pressure and Circulation 

Some supplements lower blood pressure, and cannabis may do the same. Together, they could lead to light-headedness or dizziness, especially in heat or during postural changes. 

Monitoring and Adjusting Safely 

Keeping track of symptoms and introducing one new element at a time can reduce the chance of adverse ME/CFS, cannabis safety, and supplements concerns. 

In the end, understanding the risks of cannabis and supplements for ME/CFS means approaching your care plan with awareness, patience and a willingness to adapt. 

Visit providers like LeafEase for personalised consultations and lawful, medically guided pain management options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Myalgic Encephalomyelitis (ME/CFS)

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories